hepatitis C therapy (Immune Network)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namehepatitis C therapy (Immune Network)

Drug Alias Nameimmunomodulator (Immune Network)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionImmunomodulators

TargetsUpdating

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmune Network

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesImmune Network

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A